Literature DB >> 23169761

The behavioral phenotype in MECP2 duplication syndrome: a comparison with idiopathic autism.

Sarika U Peters1, Rachel J Hundley, Amy K Wilson, Zachary Warren, Alison Vehorn, Claudia M B Carvalho, James R Lupski, Melissa B Ramocki.   

Abstract

Alterations in the X-linked gene MECP2 encoding the methyl-CpG-binding protein 2 have been linked to autism spectrum disorders (ASDs). Most recently, data suggest that overexpression of MECP2 may be related to ASD. To better characterize the relevance of MECP2 overexpression to ASD-related behaviors, we compared the core symptoms of ASD in MECP2 duplication syndrome to nonverbal mental age-matched boys with idiopathic ASD. Within the MECP2 duplication group, we further delineated aspects of the behavioral phenotype and also examined how duplication size and gene content corresponded to clinical severity. We compared ten males with MECP2 duplication syndrome (ages 3-10) with a chronological and mental age-matched sample of nine nonverbal males with idiopathic ASD. Our results indicate that boys with MECP2 duplication syndrome share the core behavioral features of ASD (e.g. social affect, restricted/repetitive behaviors). Direct comparisons of ASD profiles revealed that a majority of boys with MECP2 duplication syndrome are similar to idiopathic ASD; they have impairments in social affect (albeit to a lesser degree than idiopathic ASD) and similar severity in restricted/repetitive behaviors. Nonverbal mental age did not correlate with severity of social impairment or repetitive behaviors. Within the MECP2 duplication group, breakpoint size does not predict differences in clinical severity. In addition to social withdrawal and stereotyped behaviors, we also found that hyposensitivity to pain/temperature are part of the behavioral phenotype of MECP2 duplication syndrome. Our results illustrate that overexpression/increased dosage of MECP2 is related to core features of ASD.
© 2012 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23169761      PMCID: PMC3578988          DOI: 10.1002/aur.1262

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  42 in total

1.  MECP2 Duplication Syndrome.

Authors:  H Van Esch
Journal:  Mol Syndromol       Date:  2011-07-05

2.  Linking MECP2 and pain sensitivity: the example of Rett syndrome.

Authors:  Jenny Downs; Sandrine M Géranton; Ami Bebbington; Peter Jacoby; Nadia Bahi-Buisson; David Ravine; Helen Leonard
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

3.  Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28.

Authors:  Michael J Friez; Julie R Jones; Katie Clarkson; Herbert Lubs; Dianne Abuelo; Jo-Ann Blaymore Bier; Shashidhar Pai; Richard Simensen; Charles Williams; Philip F Giampietro; Charles E Schwartz; Roger E Stevenson
Journal:  Pediatrics       Date:  2006-11-06       Impact factor: 7.124

4.  Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities.

Authors:  Rodney C Samaco; Caleigh Mandel-Brehm; Hsiao-Tuan Chao; Christopher S Ward; Sharyl L Fyffe-Maricich; Jun Ren; Keith Hyland; Christina Thaller; Stephen M Maricich; Peter Humphreys; John J Greer; Alan Percy; Daniel G Glaze; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

5.  MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients.

Authors:  Ana M Coutinho; Guiomar Oliveira; Cécile Katz; Jinong Feng; Jin Yan; Chunmei Yang; Carla Marques; Assunção Ataíde; Teresa S Miguel; Luís Borges; Joana Almeida; Catarina Correia; António Currais; Celeste Bento; Luísa Mota-Vieira; Teresa Temudo; Mónica Santos; Patrícia Maciel; Steve S Sommer; Astrid M Vicente
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-06-05       Impact factor: 3.568

6.  MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism.

Authors:  Akane Shibayama; Edwin H Cook; Jinong Feng; Cecile Glanzmann; Jin Yan; Nick Craddock; Ian R Jones; David Goldman; Leonard L Heston; Steve S Sommer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-07-01       Impact factor: 3.568

Review 7.  Reversibility of functional deficits in experimental models of Rett syndrome.

Authors:  Stuart Cobb; Jacky Guy; Adrian Bird
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

8.  Inverted genomic segments and complex triplication rearrangements are mediated by inverted repeats in the human genome.

Authors:  Claudia M B Carvalho; Melissa B Ramocki; Davut Pehlivan; Luis M Franco; Claudia Gonzaga-Jauregui; Ping Fang; Alanna McCall; Eniko Karman Pivnick; Stacy Hines-Dowell; Laurie H Seaver; Linda Friehling; Sansan Lee; Rosemarie Smith; Daniela Del Gaudio; Marjorie Withers; Pengfei Liu; Sau Wai Cheung; John W Belmont; Huda Y Zoghbi; P J Hastings; James R Lupski
Journal:  Nat Genet       Date:  2011-10-02       Impact factor: 38.330

9.  A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome.

Authors:  Rodney C Samaco; John D Fryer; Jun Ren; Sharyl Fyffe; Hsiao-Tuan Chao; Yaling Sun; John J Greer; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Hum Mol Genet       Date:  2008-03-04       Impact factor: 6.150

10.  Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication.

Authors:  Francesca Ariani; Francesca Mari; Chiara Pescucci; Ilaria Longo; Mirella Bruttini; Ilaria Meloni; Giuseppe Hayek; Raffaele Rocchi; Michele Zappella; Alessandra Renieri
Journal:  Hum Mutat       Date:  2004-08       Impact factor: 4.878

View more
  20 in total

1.  Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing.

Authors:  Maria Fernanda Montiel-Gonzalez; Isabel Vallecillo-Viejo; Guillermo A Yudowski; Joshua J C Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-09       Impact factor: 11.205

Review 2.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

Review 3.  Lessons learned from studying syndromic autism spectrum disorders.

Authors:  Yehezkel Sztainberg; Huda Y Zoghbi
Journal:  Nat Neurosci       Date:  2016-10-26       Impact factor: 24.884

4.  Induced gamma oscillations differentiate familiar and novel voices in children with MECP2 duplication and Rett syndromes.

Authors:  Sarika U Peters; Reyna L Gordon; Alexandra P Key
Journal:  J Child Neurol       Date:  2014-04-27       Impact factor: 1.987

5.  Brief report: regression timing and associated features in MECP2 duplication syndrome.

Authors:  S U Peters; R J Hundley; A K Wilson; C M B Carvalho; J R Lupski; M B Ramocki
Journal:  J Autism Dev Disord       Date:  2013-10

Review 6.  DNA modifications: function and applications in normal and disease States.

Authors:  Vichithra R B Liyanage; Jessica S Jarmasz; Nanditha Murugeshan; Marc R Del Bigio; Mojgan Rastegar; James R Davie
Journal:  Biology (Basel)       Date:  2014-10-22

7.  MicroRNAs downregulated in neuropathic pain regulate MeCP2 and BDNF related to pain sensitivity.

Authors:  Melissa T Manners; Yuzhen Tian; Zhaolan Zhou; Seena K Ajit
Journal:  FEBS Open Bio       Date:  2015-08-31       Impact factor: 2.693

Review 8.  An inside job: how endosomal Na(+)/H(+) exchangers link to autism and neurological disease.

Authors:  Kalyan C Kondapalli; Hari Prasad; Rajini Rao
Journal:  Front Cell Neurosci       Date:  2014-06-23       Impact factor: 5.505

9.  Mild expression differences of MECP2 influencing aggressive social behavior.

Authors:  Martesa Tantra; Christian Hammer; Anne Kästner; Liane Dahm; Martin Begemann; Chiranjeevi Bodda; Kurt Hammerschmidt; Ina Giegling; Beata Stepniak; Aracely Castillo Venzor; Bettina Konte; Begun Erbaba; Annette Hartmann; Asieh Tarami; Walter Schulz-Schaeffer; Dan Rujescu; Ashraf U Mannan; Hannelore Ehrenreich
Journal:  EMBO Mol Med       Date:  2014-05       Impact factor: 12.137

10.  Phenotypic features in MECP2 duplication syndrome: Effects of age.

Authors:  Sarika U Peters; Cary Fu; Eric D Marsh; Tim A Benke; Bernard Suter; Steve A Skinner; David N Lieberman; Shannon Standridge; Mary Jones; Arthur Beisang; Timothy Feyma; Peter Heydeman; Robin Ryther; Daniel G Glaze; Alan K Percy; Jeffrey L Neul
Journal:  Am J Med Genet A       Date:  2020-11-10       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.